Skip to content

Author

Bing-Wei Zhang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

The ATTAIN Technique (Amplatz lefT guiding caTheter pArtIal deploymeNt): An Alternative Approach for Transradial Stenting of Low-Origin Vertebral Artery Ostial Stenosis.

OBJECTIVE To assess technical feasibility and procedural features of the Amplatz Left (AL) guiding catheter-assisted partial deployment (ATTAIN) technique for selected right-sided low-origin vertebral artery ostial stenosis (VAOS). METHODS We prospectively studied 10 consecutive patients. Technical success required accurate balloon-expandable drug-eluting stent placement and expansion without access crossover, guide-catheter exchange, or salvage techniques. Safety outcomes included 30-day neurological and access-site events and follow-up stent-related events. Preprocedural assessment considered vertical ostial depth (VOD) and subclavian-vertebral geometry. RESULTS During the 17-month enrollment period, technical success was achieved in 9 of 10 patients (90%). Median age was 71.5 years (IQR, 69-74); median VOD was 12.5 mm (IQR, 11-16). Among successful procedures, median deployment time was 28 minutes (IQR, 22-32). Median stenosis decreased from 76.5% (IQR, 73%-83%) to 2.5% (IQR, 0%-9%). At 3 months, symptoms completely resolved in 6 patients, partially improved in 2, and remained unchanged in 2; all had modified Rankin Scale scores of 0 or 1. No clinically apparent stroke, transient ischemic attack, or death occurred within 30 days; one unconfirmed minor access-site event was recorded. At a median 8-month follow-up (IQR, 5-11; range, 3-15), 9 patients underwent imaging, no stent fracture or in-stent restenosis was identified. CONCLUSIONS In this proof-of-concept series, the ATTAIN technique showed preliminary feasibility and provided a standardized AL guiding-catheter-assisted deployment sequence for selected right-sided low-origin VAOS. Comparative efficacy, definitive safety, and left-sided applicability remain unestablished.

Han-Ming Ge, Xiao-Bo Zhang, Zhanhua Liang et al. · 0 citations